Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. vs UNICHEM LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MARKSANS PHARMA. UNICHEM LAB MARKSANS PHARMA./
UNICHEM LAB
 
P/E (TTM) x 21.5 236.1 9.1% View Chart
P/BV x 3.9 1.4 277.3% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 MARKSANS PHARMA.   UNICHEM LAB
EQUITY SHARE DATA
    MARKSANS PHARMA.
Mar-23
UNICHEM LAB
Mar-23
MARKSANS PHARMA./
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs74467 15.9%   
Low Rs39226 17.1%   
Sales per share (Unadj.) Rs40.9190.7 21.4%  
Earnings per share (Unadj.) Rs5.9-28.7 -20.4%  
Cash flow per share (Unadj.) Rs7.0-12.6 -55.5%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %0.90-  
Book value per share (Unadj.) Rs38.5344.2 11.2%  
Shares outstanding (eoy) m453.1670.41 643.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.41.8 76.2%   
Avg P/E ratio x9.7-12.1 -80.1%  
P/CF ratio (eoy) x8.1-27.5 -29.4%  
Price / Book Value ratio x1.51.0 145.9%  
Dividend payout %8.50-   
Avg Mkt Cap Rs m25,63124,396 105.1%   
No. of employees `000NANA-   
Total wages/salary Rs m2,3943,564 67.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m18,52113,430 137.9%  
Other income Rs m593385 154.0%   
Total revenues Rs m19,11513,815 138.4%   
Gross profit Rs m3,393-841 -403.4%  
Depreciation Rs m5191,134 45.7%   
Interest Rs m91173 52.7%   
Profit before tax Rs m3,377-1,764 -191.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m723259 279.7%   
Profit after tax Rs m2,653-2,022 -131.2%  
Gross profit margin %18.3-6.3 -292.5%  
Effective tax rate %21.4-14.7 -146.1%   
Net profit margin %14.3-15.1 -95.1%  
BALANCE SHEET DATA
Current assets Rs m16,99715,885 107.0%   
Current liabilities Rs m3,6546,396 57.1%   
Net working cap to sales %72.070.7 102.0%  
Current ratio x4.72.5 187.3%  
Inventory Days Days651 11.1%  
Debtors Days Days821,600 5.1%  
Net fixed assets Rs m5,24615,911 33.0%   
Share capital Rs m453141 321.8%   
"Free" reserves Rs m16,99824,092 70.6%   
Net worth Rs m17,45224,233 72.0%   
Long term debt Rs m0636 0.0%   
Total assets Rs m22,24231,829 69.9%  
Interest coverage x38.0-9.2 -413.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.4 197.3%   
Return on assets %12.3-5.8 -212.4%  
Return on equity %15.2-8.3 -182.2%  
Return on capital %19.9-6.4 -310.7%  
Exports to sales %069.7 0.0%   
Imports to sales %7.312.4 58.6%   
Exports (fob) Rs mNA9,366 0.0%   
Imports (cif) Rs m1,3481,669 80.8%   
Fx inflow Rs m6,4919,366 69.3%   
Fx outflow Rs m1,3481,669 80.8%   
Net fx Rs m5,1437,697 66.8%   
CASH FLOW
From Operations Rs m2,374-851 -279.0%  
From Investments Rs m-2,5922,028 -127.8%  
From Financial Activity Rs m1,978-813 -243.3%  
Net Cashflow Rs m1,760746 236.1%  

Share Holding

Indian Promoters % 43.9 70.2 62.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 20.3 11.3 179.7%  
FIIs % 15.6 0.8 1,851.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 56.2 29.8 188.5%  
Shareholders   237,377 20,877 1,137.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MARKSANS PHARMA. With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on MARKSANS PHARMA. vs Unichem Lab

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

MARKSANS PHARMA. vs Unichem Lab Share Price Performance

Period MARKSANS PHARMA. Unichem Lab S&P BSE HEALTHCARE
1-Day 0.46% 1.90% 1.18%
1-Month -0.72% -5.40% -0.75%
1-Year 109.61% 78.12% 61.82%
3-Year CAGR 45.11% 16.06% 18.16%
5-Year CAGR 43.62% 19.87% 19.79%

* Compound Annual Growth Rate

Here are more details on the MARKSANS PHARMA. share price and the Unichem Lab share price.

Moving on to shareholding structures...

The promoters of MARKSANS PHARMA. hold a 43.9% stake in the company. In case of Unichem Lab the stake stands at 70.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of MARKSANS PHARMA. and the shareholding pattern of Unichem Lab.

Finally, a word on dividends...

In the most recent financial year, MARKSANS PHARMA. paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 8.5%.

Unichem Lab paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of MARKSANS PHARMA., and the dividend history of Unichem Lab.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.